Transdermal Drug Delivery Systems Market: By Application (Cardiovascular, Contraception, Pain Management / Neurological Disorders, Smoking Cessation, Others), By Technology (Electric Current, Electroporation, Radio Frequency, Thermal, Ultrasound, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Transdermal drug delivery systems market size was valued at USD 53,721.5 million in 2022, growing at a CAGR of 5.1% from 2023 to 2029. Transdermal Drug Delivery Systems Market is the self-contained, discrete dosage applied in the form of patches to the intact skin and delivers medication through the controlled rate. The main aim of transdermal patches is to deliver the medication into the systemic circulation at controlled rates to minimize the intra and interpatient variation. Transdermal drug delivery methods enable systemic drug circulation and maintain clinically efficacious concentrations at a predefined pace with minimum inter-and intrapatient variation by delivering the drug through the skin. It's a medicated adhesive bandage that sticks to the skin and releases the medicine into the bloodstream. It lessens the strain on the digestive tract and liver that comes with taking pills orally. It increases therapeutic efficacy and safety, keeps drug levels stable in the blood, and solves the drawbacks of traditional oral dosage forms and parenteral formulations. The global market provides a detailed overview and which can be segmented by technology, application, and region. By technology, the transdermal drug delivery systems market has been segmented into electric current, electroporation, radio frequency, thermal, ultrasound, and others. By technology, the electroporation segment is expected to have a significant growth rate over the forecasted period due to the increasing high for electroporation technology in the field of transdermal drug delivery globally. Based on application, the segment has been segregated into cardiovascular, contraception, pain management / neurological disorders, smoking cessation, and others. By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.  

 

Transdermal Drug Delivery Systems Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.1%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Transdermal Drug Delivery Systems Market Dynamics

An increase in the global population has significantly increased the demand for geriatric medicines. Also, transdermal drug delivery systems help deliver drugs in a controlled manner, thereby increasing the effectiveness of geriatric medicines. Apart from this, the number of patients suffering from chronic diseases, such as heart disease, diabetes, and arthritis has steadily increased these days, and also these chronic diseases are a leading cause of disability and death globally. Additionally, rising awareness among patients, regarding the use of enormous medicines has also increased. These factors have impacted positively the global transdermal drug delivery systems market growth.

Key Features of the Reports

  • The transdermal drug delivery market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Transdermal Drug Delivery Systems Market Segmentation

By Application
  • Cardiovascular
  • Contraception
  • Pain Management / Neurological Disorders
  • Smoking Cessation
  • Others
By Technology
  • Electric Current
  • Electroporation
  • Radio Frequency
  • Thermal
  • Ultrasound
  • Others
By Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

By application, the pain management segment is expected to account for the majority of the share of the transdermal drug delivery systems market attributing to the high burden of chronic pain globally and the increasing availability of transdermal products for pain management.

The major factors driving the market growth are the increases in the demand for self-administration of drugs for the long-term treatment of diverse disorders.

Business expansion is a key growth strategy opted by industry players of transdermal drug delivery system.

1. Executive Summary
2. Global Transdermal Drug Delivery Systems Market Introduction 
2.1.Global Transdermal Drug Delivery Systems Market  - Taxonomy
2.2.Global Transdermal Drug Delivery Systems Market  - Definitions
2.2.1.Application
2.2.2.Technology
2.2.3.Region
3. Global Transdermal Drug Delivery Systems Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Transdermal Drug Delivery Systems Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Transdermal Drug Delivery Systems Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Cardiovascular
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Contraception
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Pain Management / Neurological Disorders
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Smoking Cessation
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Transdermal Drug Delivery Systems Market  By Technology, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Electric Current
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Electroporation
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Radio Frequency
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Thermal
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Ultrasound
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Transdermal Drug Delivery Systems Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Transdermal Drug Delivery Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Cardiovascular
8.1.2.Contraception
8.1.3.Pain Management / Neurological Disorders
8.1.4.Smoking Cessation
8.1.5.Others
8.2.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Electric Current
8.2.2.Electroporation
8.2.3.Radio Frequency
8.2.4.Thermal
8.2.5.Ultrasound
8.2.6.Others
8.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Transdermal Drug Delivery Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cardiovascular
9.1.2.Contraception
9.1.3.Pain Management / Neurological Disorders
9.1.4.Smoking Cessation
9.1.5.Others
9.2.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Electric Current
9.2.2.Electroporation
9.2.3.Radio Frequency
9.2.4.Thermal
9.2.5.Ultrasound
9.2.6.Others
9.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10. Asia Pacific (APAC) Transdermal Drug Delivery Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cardiovascular
10.1.2.Contraception
10.1.3.Pain Management / Neurological Disorders
10.1.4.Smoking Cessation
10.1.5.Others
10.2.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Electric Current
10.2.2.Electroporation
10.2.3.Radio Frequency
10.2.4.Thermal
10.2.5.Ultrasound
10.2.6.Others
10.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Transdermal Drug Delivery Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cardiovascular
11.1.2.Contraception
11.1.3.Pain Management / Neurological Disorders
11.1.4.Smoking Cessation
11.1.5.Others
11.2.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Electric Current
11.2.2.Electroporation
11.2.3.Radio Frequency
11.2.4.Thermal
11.2.5.Ultrasound
11.2.6.Others
11.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Transdermal Drug Delivery Systems Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Application Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cardiovascular
12.1.2.Contraception
12.1.3.Pain Management / Neurological Disorders
12.1.4.Smoking Cessation
12.1.5.Others
12.2.  Technology Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Electric Current
12.2.2.Electroporation
12.2.3.Radio Frequency
12.2.4.Thermal
12.2.5.Ultrasound
12.2.6.Others
12.3.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1. Novartis AG (Switzerland)
13.2.2. Boehringer Ingelheim GmbH (Germany)
13.2.3. Generex Biotechnology Corp. (Canada)
13.2.4. Echo Therapeutics, Inc. (U.S.)
13.2.5. Crescita Therapeutics Inc (Canada)
13.2.6. MedPharm (U.K.)
13.2.7. Pantec Biosolutions AG (Liechtenstein)
13.2.8. Transdermal Corp. (U.S.)
13.2.9. Noven Pharmaceuticals, Inc. (U.S.)
13.2.10. Actelion Pharmaceuticals Ltd (Switzerland)
13.2.11. Johnson & Johnson Limited (U.S.)
13.2.12. 3M Pharmaceuticals Inc. (U.S.)
13.2.13. Mylan Pharmaceuticals Inc. (U.S.)
13.2.14. GlaxoSmithKline plc (U.K.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Novartis AG (Switzerland)
  • Boehringer Ingelheim GmbH (Germany)
  • Generex Biotechnology Corp. (Canada)
  • Echo Therapeutics, Inc. (U.S.)
  • Crescita Therapeutics Inc (Canada)
  • MedPharm (U.K.)
  • Pantec Biosolutions AG (Liechtenstein)
  • Transdermal Corp. (U.S.)
  • Noven Pharmaceuticals, Inc. (U.S.)
  • Actelion Pharmaceuticals Ltd (Switzerland)
  • Johnson & Johnson Limited (U.S.)
  • 3M Pharmaceuticals Inc. (U.S.)
  • Mylan Pharmaceuticals Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)

Adjacent Markets